Growth velocity and interleukin 6 concentrations in juvenile idiopathic arthritis

J Rheumatol. 2008 Nov;35(11):2265-71. doi: 10.3899/jrheum.080199. Epub 2008 Oct 1.

Abstract

Objective: .To evaluate associations of growth velocity with inflammatory markers and cumulative dose of glucocorticoid in a cohort of patients with juvenile idiopathic arthritis (JIA) followed during 1 year.

Methods: Seventy-nine patients were evaluated. Disease activity was evaluated by a pediatric rheumatologist. Anthropometric data were classified according to the World Health Organization standards. Tanner growth velocity curves were used; values below the Z-score < or = -2 were considered low growth velocity. Serum concentrations of interleukin 6 (IL-6) were measured by ELISA, and values > 1 pg/ml were considered elevated.

Results: The prevalence of low growth velocity was 25.3%, and it was associated with active disease on followup visit, elevated IL-6, erythrocyte sedimentation rate and C-reactive protein, and higher cumulative glucocorticoid doses. In the multiple linear regression with growth velocity as the dependent variable, only elevated IL-6 level was independently and negatively associated with growth velocity.

Conclusion: Low growth velocity is highly prevalent in children with JIA. Elevated IL-6 levels seem to have an important negative influence on growth in these children, while total glucocorticoid exposure appears to be a secondary factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Anthropometry
  • Arthritis, Juvenile / drug therapy
  • Arthritis, Juvenile / epidemiology*
  • Arthritis, Juvenile / immunology*
  • Biomarkers / blood
  • Child
  • Female
  • Glucocorticoids / therapeutic use
  • Growth Disorders / epidemiology*
  • Growth Disorders / immunology*
  • Humans
  • Interleukin-6 / blood*
  • Linear Models
  • Male
  • Prevalence
  • Puberty

Substances

  • Biomarkers
  • Glucocorticoids
  • IL6 protein, human
  • Interleukin-6